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 With the development of technology, the clinical study related to disease detection 
has become a popular topic for biostatisticians. For those studies, the combination of 
multiple diagnostic tests seems to be the most general tool to achieve optimal sensitivity 
and specificity. In this thesis, we apply the exponential tilting model proposed by Qin 
and Zhang (2010) and the monotonic density ratio model proposed by Chen et al. (2015) 
to estimate the asymptotic distribution for 𝜷  and 𝐴𝑈𝐶  using three bootstrapping 
methods and give an evaluation and comparison towards their performances. We give 
a good estimation for the distribution of 𝜷 no matter whether the robustness is taken 
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 With the medical technology developing rapidly, people become more and more 
enthusiastic to the clinical study related to disease detection in the early stage when the 
patient in fact doesn’t have any obvious symptoms yet. This kind of early detection, or 
in other words, screening, grows to be a popular topic for biostatisticians because these 
trials can find the possible disease earlier with less cost and significantly reduce the 
death rate.  
Among those clinical researches, the studies about biomarkers towards disease 
detections and classifications seem to be the essential part and have considerable 
research results according to Henson et al. (1999) and Srinivas et al. (2001). However, 
those tumor biomarkers, for example, CA-125 for diagnosing ovarian cancer, are 
accurately not perfect in performance for disease detecting. Many diseased individuals 
may have normal tumor biomarker concentrations, causing false negative diagnostic 
tests, while many non-diseased individuals may also have strange biomarker 
concentrations, leading to unnecessary diagnostic work-up and possible further 
treatments. Therefore, diagnostic tests, especially multiple diagnostic tests, are usually 
used for screening and diagnostic program, while the specificity and sensitivity of a 
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single diagnostic test cannot meet the researchers’ needs in practice. And the 
combination of multiple diagnostic tests can further increase the accuracy of testing and 
then obtain an optimal testing method, so that those hidden diseases can be detected 
earlier and those diseased and non-diseased individuals can be distinguished more 
easily and accurately. 
 In clinical practice, many diagnostic testing methods are available for detecting 
possible diseases. And researchers can find that different diagnostic tests are sensitive 
to different aspects of the disease. Therefore, in recent several years, researchers are 
keen to find the best combination of multiple diagnostic tests for different assumptions. 
Kay and Little (1987) discussed various versions of the density ratio model by 
transforming the variables in the logistic regression model for binary data. If they 
assume that the variable satisfies a multivariate normal distribution, Su and Liu (1993) 
found the best way to combine different multiple diagnostic tests. By applying the 
Neyman-Pearson fundamental lemma, Eguchi and Copas (2002), Copas and Corbett 
(2002), and McIntosh and Pepe (2002) found the best combination of multiple 
diagnostic tests using log density ratio statistic for diseased and non-diseased 
individuals. Etzioni et al. (2003) took logistic combinations towards biomarkers to 
detect disease for cancers. Yuan and Ghosh (2008) came out with a novel model-
combining algorithm when they combined multiple biomarker models in logistic 
regression. Liu and Zhou (2013) took the covariate adjustment into account and then 
studied the optimal combination in this case. Qin and Zhang (2010) assumed that the 
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diseased and non-diseased population has a log density ratio and proposed an 
exponential titling model as a combination of multiple diagnostic tests. Chen et al. 
(2015) considered a semiparametric monotonic model by directly modeling the density 
ratio as an unspecified monotonic non-decreasing function of a combination of multiple 
tests between those two groups of individuals. More development about the 
combination of multiple diagnostic tests can be found in the papers written by Barreno 
et al. (2008), and Kim et al. (2013). The last two models proposed by Qin and Zhang 
(2010) and Chen et al. (2015) will be introduced in detail and applied in future chapters. 
 And when the sampling distribution of the diagnostic variable is continuous, the 
ROC curve, or to be more precisely, the receiver operating characteristic curve, is one 
of the most widely used techniques for assessing the diagnostic accuracy in disease 
detection. To further classify the accuracy of the proposed method, 𝐴𝑈𝐶 (the area 
under the ROC curve) is often applied for estimating the performance. Back to the 
whole research history, the estimations related to the ROC curve and the corresponding 
𝐴𝑈𝐶  are always based on a parametric model, a semiparametric model, or a fully 
nonparametric model. If we take some reading of the papers written by Begg (1991), 
Hsieh and Turnbull (1996), Zhou et al. (2002), Krzanowski and Hand (2009), Pepe 
(2003) and Zou et al. (2011), it is supposed to have a more comprehensive reviews of 
the development of the applications based on the ROC curve and the corresponding 
𝐴𝑈𝐶 in recent years. 
4 
 
 This thesis is going to mainly discuss the application of the ROC curve to estimate 
the accuracy of the optimal combinations proposed by Qin and Zhang (2010) and Chen 
et al. (2015). Moreover, in Chen et al. (2015), they have proceeded to establish the 
convergence rate of 𝜷  and the 𝐴𝑈𝐶  for the proposed method. Here 𝜷  is the 
parameter of the semiparametric monotonic density ratio model which satisfies: 
𝑓(𝒙)
𝑔(𝒙)
= 𝜓(𝑣(𝒙, 𝜷)) 
where 𝜓(. )  is an unknown monotonic non-decreasing function, and 𝑣(𝒙, 𝜷) =
𝜷𝑇ℎ(𝒙). 
 But in Chen et al. (2015), it only gave an estimation of the convergence rates for 
these two parameters, while their asymptotic distributions are actually still in mystery, 
inspiring us to have deeper exploration towards this problem. Therefore, this thesis will 
apply bootstrapping and resampling methods to show the empirical distributions for 𝜷 
and 𝐴𝑈𝐶 and estimate the accuracy with different parameter settings, which is the 
main part of this thesis. 
 This thesis will be organized as follows. In Chapter 2, we will introduce some basic 
concepts which will be applied later in this thesis. In Chapter 3, we will describe those 
two optimal combinations of multiple diagnostic tests proposed by Qin and Zhang 
(2010) and Chen et al. (2015) and some related asymptotic results. In Chapter 4, we 
will describe the methods for estimating the asymptotic distribution of  𝜷 and 𝐴𝑈𝐶 
in detail. In Chapter 5, we will do some simulation studies to give an evaluation of the 
methods of estimating distributions we have already described in Chapter 4, with those 
5 
 
biomarkers following bivariate exponential distribution. A conclusion remark and 






Basic concepts  
 
2.1 ROC and AUC 
The ROC (receiver operating characteristic) curve is a graphical plot that can 
evaluate the performance of a diagnostic test. It was first used during the period of 
World War II when the United States army tried to analyze the radar signals and predict 
the routes of Japanese aircrafts. Its employment in signal detection extended to 
medicine in 1950s to assess human detection of weak signals according to Green and 
Swets (1966). The ROC curve was then extensively applied in medical research, 
epidemiology, machine learning and the evaluation of diagnostic tests, which we can 
find more details from Zweig and Campbell (1993). It also became a common technique 
to evaluate radiology technique. 
The ROC curve can be created by plotting the true positive rate (TPR), also known 






  Predicted condition 









Ture positive rate 
(sensitivity) 
False negative rate 
(Type II error) 
Condition 
negative 
False positive rate 
(Type I error) 
True negative rate 
(1-specificity) 
Table 1. 2 × 2 contingency table 
 
From Swets (2014), only the rates TPR(T) and FPR(T) are needed for plotting 
the ROC curve. The TPR is the ratio describing how many correct positive results occur 
among all positive samples appeared in the test. On the other hand, the FPR is the ratio 
describing how many incorrect positive results occur among all negative samples 
appeared in the test. For a single diagnostic test, if 𝐹 and 𝐺 denote the cumulative 
distribution functions for the test result in the diseased and non-diseased individuals, 
and 𝑓 and 𝑔 denote the probability density functions for them, then TPR(T) and 
FPR(T) can be represented as: 








And the ROC curve has the following representation: 
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𝑅𝑂𝐶(𝑠) = 1 − F(𝐺−1(1 − s)), s ∈ (0,1). 
 As a classifier to measure the efficacy, 𝐴𝑈𝐶 (the area under the curve) will often 
be applied, which is given by: 




If we define 𝐴𝑈𝐶 directly from the rates TPR(T) and FPR(T), then it can be 
represented as: 









𝑓(𝑇′)𝑔(𝑇)𝑑𝑇′𝑑𝑇 = 𝑃(𝑋1 > 𝑋0) 
where 𝑋1 is the score for the positive distance and 𝑋0 is the score for the negative 
distance. It should be noted that those two expressions above are equivalent in 
mathematics. 
 This ROC-AUC statistic is widely applied in many different fields nowadays. 
Sometimes researchers will link this statistic to a number of other performance metrics 
such as Brier score described in Hernández (2012) to reduce the noise when it is applied 







2.2 Bootstrapping and resampling 
Bootstrapping refers to some tests based on random sampling with replacement in 
statistics. This method was first published by Bradley Efron (1992). It is a popular and 
straightforward technology that can be applied to assign measures of accuracy, such as 
bias, variance, confidence intervals and prediction error for some complex estimators 
of complex parameters of the distribution. It may also be used for constructing 
hypothesis tests.  
When bootstrapping is used to calculate confidence intervals for the population-
parameter, we can first approximate the distribution by referring to the empirical 
distribution function of the observed data. In the case where the observations are 
assumed to be an independent and identically distributed dataset, this distribution can 
be obtained by constructing a number of resampling with replacement from the 
observed dataset. The size of the new dataset can be smaller or equal to the initial 
dataset. If we set the confidence level equal to α  and using percentiles of the 
bootstrapping distribution, a confidence interval can be obtained as follows: 
(𝜃𝛼/2
∗ , 𝜃1−𝛼/2
∗ ) , where 𝜃𝛼/2
∗  denotes the α/2  percentile of the bootstrapped 
coefficients 𝜃∗. 
Except this kind of classical way of bootstrapping, various alternatives are 
available for regression problems such as Bayesian bootstrapping, smooth 
bootstrapping, wild bootstrapping described by Wu (1986) and block bootstrapping 
described by Hernández (1989). 
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Bootstrapping method work well in those cases where the bootstrapping 
distribution is symmetrical and centered on the observed statistics and where the sample 
statistic is median-unbiased and has maximum concentration. And due to the 
development of computing power, it is recommended to increase the number of 
bootstrapping samples as many as possible, so that the effects of random sampling 






Optimal combination of multiple diagnostic tests 
 
 Suppose that there are K tests in total, with the kth test denoted as ℵ𝑘 for k =
1, … , K . Let {𝑻1, … , 𝑻𝑛}  denote the combined K-vector {𝑿1, … , 𝑿𝑛0; 𝒀1, … , 𝒀𝑛1} , 
where 𝑿1, … , 𝑿𝑛0 represent independent and identically distributed results from the 
non-diseased individuals, and 𝒀1, … , 𝒀𝑛1  represent independent and identically 
distributed results from the diseased individuals. Here 𝑿𝑖 , 𝒀𝑖  are all K-vector 
represented as (ℵ1, … ℵ𝐾)
𝜏 , and 𝑛0 ,  𝑛1  are the sample size for non-diseased and 
diseased individuals with 𝑛 = 𝑛0 + 𝑛1 , 𝑛  refers to the size of the whole sample 
dataset. Let 𝐷 = 1 and 𝐷 = 0 refer to the diseased and non-diseased status, and let 
𝐹(𝒙) = 𝑃(𝑿 ≤ 𝒙|𝐷 = 1)  and 𝐺(𝒙) = 𝑃(𝑿 ≤ 𝒙|𝐷 = 0)  represent the cumulative 
distribution functions of 𝑿𝑖  and 𝒀𝑖 ,  𝑓(𝒙)  and 𝑔(𝒙)  are the corresponding 
possibility density functions.  
 
3.1 Optimal combination based on exponential titling model 
In Qin and Zhang (2010), they consider an exponential titling model, which we 
will call it model (1) in short. For a given K in 𝐗 = 𝐱 , the conditional 
distribution 𝑃(𝐷 = 1|𝑿 = 𝒙) is given by the logistic regression model: 
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𝑃(𝐷 = 1|𝑿 = 𝒙) =
exp(𝛼∗ + 𝜷𝜏ℎ(𝒙))
1 + exp(𝛼∗ + 𝜷𝜏ℎ(𝒙))
 
And this model is equivalent to represent the density ratio as followed: 
𝑓(𝒙)
𝑔(𝒙)
= exp(𝛼 + 𝜷𝜏ℎ(𝒙)) 
where α is a scalar parameter, 𝜷 is a p × 1 vector parameter, and ℎ(𝒙) is a p × 1 
smooth vector function of 𝒙. 
Here U = 𝛼 + 𝜷𝜏ℎ(𝒙) is the optimal combination. It can be evaluated by plotting 
the receiver of characteristic 𝑅𝑂𝐶𝐶(s)： 
𝑅𝑂𝐶𝐶(s) = 1 − 𝐹𝑐(𝐺𝐶
−1(1 − s)), s ∈ (0,1) 
where 𝐹𝑐(𝑢) = P(U ≤ u|D = 1)  and 𝐺𝑐(𝑢) = P(U ≤ u|D = 0) , the corresponding 
area under the optimal curve 𝑅𝑂𝐶𝐶(s) is given by 




 To be more specific, let {𝒕𝟏, … 𝒕𝒏} denote the observed value of {𝑻𝟏, … 𝑻𝒏}, and 
because the optimal combination of different diagnostic tests is the likelihood ratio, the 
semiparametric log likelihood function of (α, 𝛃) is given by: 
ℓ(𝛼, 𝛽) = ∑[𝛼 + 𝛽𝜏ℎ(𝒚𝒋)
𝑛1
𝑗=1




where ρ = 𝑛1/𝑛0  is assumed to converge when n → ∞ . And the maximum 






= 𝑛1 − ∑
𝜌 exp(𝛼 + 𝜷𝜏ℎ(𝒕𝒊))











𝜌 exp(𝛼 + 𝜷𝜏ℎ(𝒕𝒊))





 Under this model, the maximum semiparametric likelihood estimator of 𝐹 and 𝐺 





exp (?̃? + ?̃?𝜏ℎ(𝑻𝒊)) 𝐼(𝑻𝒊 ≤ 𝑡)













Now let U?̃? = ?̃? + ?̃?
𝜏ℎ(𝑻𝒌) for k = 1, … , n. Similar to the estimation about 𝐹 



















It may also be proposed that the estimated optimal ROC and its area (AUC) can be 
represented as: 
𝑅𝑂?̃?𝐶(s) = 1 − ?̃?𝑐 (?̃?𝐶
−1(1 − s)) , s ∈ (0,1) 






 In addition, this semiparametric estimators (𝐹?̃?(𝑢),?̃?𝐶(𝑢)) and the area under the 
estimated optimal ROC curve 𝐴𝑈𝐶?̃?  has the asymptotic behaviors as the following 
theorem: 
 
Theorem 1  
Under the model (1), for the estimator (𝐹?̃?(𝑢),?̃?𝐶(𝑢)), √𝑛(?̃?𝐶 − 𝐹𝐶) → 𝑊𝐹 and 
√𝑛(?̃?𝐶 − 𝐺𝐶) → 𝑊𝐺 weakly in ℘[−∞, ∞] as n → ∞, where ℘[−∞, ∞] refers to the 
set of all real-valued functions that are right continuous and has left-hand limits for all 
x ∈ [−∞, ∞]. And let 0 < a < b < 1 , suppose that 𝑓𝐶  and 𝑔𝐶 are the corresponding 
density functions that are continuous on [𝐺𝐶
−1(a) − ε, 𝐺𝐶
−1(𝑏) + ε] for some ε > 0, 
then  √𝑛(𝑅𝑂?̃?𝐶(𝑠) − 𝑅𝑂𝐶𝐶(𝑠)) → 𝑊[𝐺𝐶
−1(1 − s)] weakly in ℘[1 − b, 1 − a] and 
√𝑛(𝐴𝑈?̃?𝐶 − 𝐴𝑈𝐶𝐶) → 𝑁(0, 𝜎
2(𝛼0, 𝛽0, 𝐺𝐶)). Here in these relations, 𝑊𝐹, 𝑊𝐺 and  𝑊 
should satisfies some conditions.  
More details and proofs of the asymptotic results can be found in Qin and Zhang 
(2010). 
 
3.2 Optimal combination based on semiparametric monotonic 
density ratio model 
In most papers, the combination needs to specify the density ratio or the distribution 
for multiple diagnostic tests correctly to obtain the optimal combination, which is 
15 
 
difficult to realize in practice, especially when the data is high-dimensional. Therefore, 
Chen et al. (2015) directly model the density ratio as a nonparametric function of a 
combination of multiple diagnostic tests, which they think can greatly improve the 
robustness of the combination proposed by Qin and Zhang (2010). They consider a 




= 𝜓(𝑣(𝒙, 𝜷)) 
where 𝜓(. )  is an undefined monotonic non-decreasing function, and 𝑣(𝒙, 𝜷) =
𝜷𝑇ℎ(𝒙). While ROC is an invariant property, the optimal ROC curve of model (2) is 
based on the combination 𝑣(𝒙, 𝜷) = 𝜷𝑇ℎ(𝒙).  
 Let {𝒕𝟏, … 𝒕𝒏} denote the observed value of {𝑻𝟏, … 𝑻𝒏}. And: 
𝑝𝑖 = 𝑑𝐹(𝒕𝒊), 𝑞𝑖 = 𝑑𝐺(𝒕𝒊), 𝑖 = 1,2, … . , 𝑛, 
𝑚𝑖 = 𝐼(𝑡𝑖 ∈ {𝒀1, … , 𝒀𝑛1}), 𝑟𝑖 = 𝐼(𝑡𝑖 ∈ {𝑿1, … , 𝑿𝑛0}). 
 The corresponding likelihood function is 






where 𝑝𝑖, 𝑞𝑖 ≥ 0, ∑ 𝑝𝑖 = 1
𝑛
𝑖=1 ,  ∑ 𝑞𝑖 = 1
𝑛
𝑖=1 , 𝑝𝑖/𝑞𝑖 = 𝜓(𝑣(𝒕𝒊, 𝜷)). 




{𝑝?̂?, … , 𝑝?̂?, 𝑞?̂?, … , 𝑞?̂?, } = arg max
𝑝1,…,𝑝𝑛,𝑞1,…,𝑞𝑛
𝐿 
 Then we assume 𝑛1/(𝑛0 + 𝑛1) → 𝜆 ∈ (0,1)  as n → ∞ . 𝑝𝑖  and  𝑞𝑖  can be 
reparameterized to 𝜃(𝑣(𝒕𝑖; 𝛽)) and  𝜙𝑖 in this way: 
𝜃(𝑣(𝒕𝑖; 𝛽)) =
𝜆𝑝𝑖
𝜆𝑝𝑖 + (1 − 𝜆)𝑞𝑖
=
𝜆𝜓(𝑣(𝒕𝒊, 𝜷))
𝜆𝜓(𝑣(𝒕𝒊, 𝜷)) + (1 − 𝜆)
 
 𝜙𝑖 = 𝜆𝑝𝑖 + (1 − 𝜆)𝑞𝑖 
which is equivalent to: 
𝑝𝑖 =  𝜙𝑖𝜃(𝑣(𝒕𝑖; 𝜷))/𝜆 
𝑞𝑖 =
 𝜙𝑖{1 − 𝜃(𝑣(𝒕𝑖; 𝜷))}
1 − 𝜆
 
 If we apply the new-reparametrized parameters 𝜃(𝑣(𝒕𝑖; 𝜷))  and  𝜙𝑖 , the 
empirical likelihood function can be revised to 𝐿 = 𝐿1𝐿2 , with 𝐿1 , and 𝐿2  be 
expressed as: 
𝐿1 = 𝜆
−𝑛1(1 − 𝜆)−𝑛0 ∏{𝜃(𝑣(𝒕𝑖; 𝜷))}










 The maximum empirical likelihood estimators  𝜙?̂?  of  𝜙𝑖  are calculated by 





 Then the maximum empirical likelihood estimators for 𝜃(. )  and 𝛽  can be 
calculated by maximizing 𝐿1: 
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𝑀𝑛(𝜃, 𝜷) = −
1
𝑛




Θ = {𝜃(. ): 𝜃(. ) ∈ [0,1] and is monotonic increasing} 
𝐁 = {1} × 𝐁−𝟏 
It should be noted that for this semiparametric monotonic density ratio model, we 
would apply PAVA method described in Ayer (1955) to do the minimization with 
respect to 𝜃. 
 Let 𝐹𝐶(𝑢; 𝜷)  and 𝐺𝐶(𝑢; 𝜷)  be the cumulative distribution function (cdf) of 
𝑣(𝒀; 𝜷) and 𝑣(𝑿; 𝜷). Those cumulative distribution functions, the optimal ROC curve 
and its area can be estimated by: 
𝐹?̂?(𝑢) = ∑ 𝑝?̂?𝐼
𝑛
𝑖=1
((𝑣(𝒕𝑖; ?̂?) < 𝑢) 
𝐺?̂?(𝑢) = ∑ 𝑞?̂?𝐼
𝑛
𝑖=1
((𝑣(𝒕𝑖; ?̂?) < 𝑢) 
𝑅𝑂𝐶?̂?(s) = 1 − 𝐹?̂? (?̂?𝐶
−1(1 − s)) , s ∈ (0,1) 




 And the following theorem shows the convergence rate of the previous estimated 
parameters if they satisfy some conditions: 
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(a) d (𝜃(𝑣(𝒙; ?̂?), 𝜃0(𝑣(𝒙; 𝜷𝟎)))) = 𝑂𝑝(𝑛
−1/3) 
(b) ?̂? − 𝜷𝟎 = 𝑂𝑝(𝑛
−1/3) 
(c) 𝑠𝑢𝑝𝑢∈𝑹|𝐹?̂?(𝑢) − 𝐹𝐶(𝑢; 𝜷𝟎)| = 𝑂𝑝(𝑛
−1/3) and 𝑠𝑢𝑝𝑢∈𝑹|𝐺?̂?(𝑢) − 𝐺𝐶(𝑢; 𝜷𝟎)| =
𝑂𝑝(𝑛
−1/3) 
(d) |𝑅𝑂𝐶?̂?(𝑠) − 𝑅𝑂𝐶𝐶(𝑠)| = 𝑂𝑝(𝑛
−1/3) for every s ∈ (0,1) 
(e) 𝐴𝑈𝐶?̂? − 𝐴𝑈𝐶𝐶 = 𝑂𝑝(𝑛
−1/3) 
 
The conditions that the asymptotic estimations above should satisfy and the detailed 
proofs could be found in Chen et al. (2015). We will not include all these parts because 








In this chapter, we will describe the methods we are going to estimate the 
distribution for the estimated parameters 𝜷 and 𝐴𝑈𝐶. We compare the performance of 
the following methods: ①Method I based on model (2) (semiparametric monotonic 
density ratio model); ②Method II based on model (2); ③Method II based on model 
(1) (exponential titling method).  
Here Method I has the following steps: 
(a) Generate a dataset {𝑿1, … , 𝑿𝑛0; 𝒀1, … , 𝒀𝑛1}  with 𝑛0  non-diseased individuals 
and 𝑛1 diseased ones. 
(b) Do 𝐁  resamplings with replacement from the previous dataset 
{𝑿1, … , 𝑿𝑛0; 𝒀1, … , 𝒀𝑛1} , form a ‘new’ dataset {𝑿1
𝐵, … , 𝑿𝑛0
𝐵 ; 𝒀1
𝐵, … , 𝒀𝑛1
𝐵 } , here 
{𝑿1
𝐵, … , 𝑿𝑛0
𝐵 }  are from {𝑿1, … , 𝑿𝑛0} , {𝒀1
𝐵 , … , 𝒀𝑛1
𝐵 } are from {𝒀1, … , 𝒀𝑛1}  and 
then calculate the corresponding 𝜷?̂? and 𝐴𝑈𝐶𝐶
𝐵̂  for each resampling.  
(c) Collect 𝐁 estimated  𝜷?̂? and 𝐴𝑈𝐶𝐶
𝐵̂  calculated from each resampling in step (b), 
establish the asymptotic distribution of ?̂? and 𝐴𝑈𝐶?̂? from the resampling results 
and do the hypothesis test to find whether the true value 𝜷𝟎 and 𝐴𝑈𝐶𝐶 are in the 
confidence interval (α/2, 1 − α/2) with confidence level α. If the true value of 
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𝜷𝟎  or 𝐴𝑈𝐶𝐶  is in this confidence interval, then the corresponding counting 
parameter C = C + 1. 
(d) Repeat step (a)~(c) for 𝐍 times, and calculate the corresponding Type I error and 
Type II error.  
 
Method II has the following steps: 
(a) Generate a dataset {𝑿1, … , 𝑿𝑛0; 𝒀1, … , 𝒀𝑛1}  with 𝑛0  non-diseased individuals 
and 𝑛1 diseased ones. 
(b) Calculate the estimated cumulative density functions 𝐹?̂?(𝑢), 𝐺?̂?(𝑢) and 𝐴𝑈𝐶?̂? 
for the dataset {𝑿1, … , 𝑿𝑛0; 𝒀1, … , 𝒀𝑛1}. 
(c) Generate a ‘new’ dataset {𝑿1
𝑁 , … , 𝑿𝑛0
𝑁 ; 𝒀1
𝑁 , … , 𝒀𝑛1
𝑁 }  based on the dataset 
{𝑿1, … , 𝑿𝑛0; 𝒀1, … , 𝒀𝑛1} and the estimated 𝐹?̂?(𝑢), 𝐺?̂?(𝑢) calculated in step (b). 
Here ‘based on’ means that we assume that the distribution of diseased and non-
diseased individuals are known and discrete which take values among 
{𝑿1
𝑁 , … , 𝑿𝑛0
𝑁 ; 𝒀1
𝑁 , … , 𝒀𝑛1
𝑁 }. They follow the cumulative distribution function 𝐹?̂?(𝑢) 
and 𝐺?̂?(𝑢). And different from Method I, here {𝑿1
𝑁 , … , 𝑿𝑛0
𝑁 } and {𝒀1
𝑁 , … , 𝒀𝑛1
𝑁 } are 
in fact from the whole dataset {𝑿1, … , 𝑿𝑛0; 𝒀1, … , 𝒀𝑛1}. 
(d) Calculate the estimated parameters  𝜷𝑁 ̂ and 𝐴𝑈𝐶?̂?
𝑁
 for the ‘new’ dataset 
{𝑿1
𝑁 , … , 𝑿𝑛0
𝑁 ; 𝒀1




(e) Repeat this bootstrapping steps (c)~(d) for 𝐁  times, collect 𝐁  estimated  ?̂?𝑁 
and 𝐴𝑈𝐶?̂?
𝑁
calculated in step (d), establish the distribution of ?̂? and 𝐴𝑈𝐶?̂? from 
the bootstrapping results and do the hypothesis test to find whether the true value 
𝜷𝟎  and 𝐴𝑈𝐶𝐶  are in the confidence interval (α/2,1 − α/2)  with confidence 
level  α. If the true value 𝜷𝟎  or 𝐴𝑈𝐶𝐶  is in this confidence interval, then the 
corresponding counting parameter C = C + 1. 
(f) Repeat step (a)~(e) for 𝐍 times, and calculate the corresponding Type I error and 
Type II error. 
 
Here Type I error for method I and II both have the expression: 
error I𝜷 = 𝐶𝜷/𝐍 
error I𝐴𝑈𝐶 = 𝐶𝐴𝑈𝐶/𝐍 
 For Type II error of 𝜷, since we will standardize ‖𝜷‖2 = 1 in the simulation 
study in next chapter, we will set the value for hypothesis test vary from 0 to 1, with an 
interval of 0.05 and find out the value of Type II error. 
 And for 𝐴𝑈𝐶, which takes value from 0.5 to 1 if it is defined correctly, we will set 
the varying interval value equal to 0.01 around the true value because 𝐴𝑈𝐶 has a more 
concentrated distribution compared with 𝜷. We can observe the change of Type II error 
more precisely if we set the interval smaller for 𝐴𝑈𝐶. 
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 About the process of calculating Type II error, we will count the number which the 
testing value is in the confidence interval and Type II error of that value is the counting 








 In this chapter, we will estimate the distribution of ?̂? and 𝐴𝑈𝐶?̂?  and do the 
corresponding hypothesis tests to find out Type I error and Type II error while applying 
the methods described in the Chapter 4. Due to the time limit, we consider the sample 
size (𝑛0, 𝑛1) equals to (600,300) and consider a combination of two biomarkers 𝐗 =
(𝑋1, 𝑋2) . For each method, we perform 𝐁 = 100  resamplings and 𝐍 = 1000 
replications.  
In this simulation, we assume 𝐗 = (𝑋1, 𝑋2)  follows a bivariate exponential 
distribution, which we will describe it in detail in the next section. And we should also 
note that our estimation can also be applied for other distributions. 
 
5.1 Biomarkers follow exponential distribution 
 First, we study the case when the two biomarkers follow the bivariate exponential 
distribution. We posit that 𝑋1|𝐷 = 1~exp (𝜉1), 𝑋2|𝐷 = 1~exp (𝜉2), and correlation 
Corr(𝑋1, 𝑋2) = 𝜉0/(𝜉1 + 𝜉2 − 𝜉0), where 0 ≤ 𝜉0 ≤ min (𝜉1, 𝜉2), here 𝜉1 and 𝜉2 are 
rates of exponential distribution. The process for generating data is as follows: 
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(a) Generate 𝑌1 from the univariate exponential distribution with rate 𝜉1 − 𝜉0 and 
𝑌2 from the univariate exponential distribution with rate 𝜉2 − 𝜉0. 
(b) Generate Z from the univariate exponential distribution with rate 𝜉0. 
(c) Let 𝑋1 = min (𝑌1, 𝑍) and 𝑋2 = min (𝑌2, 𝑍). 
 
From the process above, the joint density function of 𝐗|𝐷 = 1  for diseased 
individuals can be easily verified: 
{
𝑓(𝒙) = 𝜉1(𝜉2 − 𝜉0)𝑒
−𝜉1𝑥1−(𝜉2−𝜉0)𝑥2  𝑖𝑓  𝑥2 < 𝑥1
𝑓(𝒙) = 𝜉2(𝜉1 − 𝜉0)𝑒
−𝜉2𝑥2−(𝜉1−𝜉0)𝑥1  𝑖𝑓 𝑥1 < 𝑥2
 
For 𝐗|𝐷 = 0, we similarly generate 𝐗 for non-diseased individuals. We apply 
different rates for different groups. For example, we set 𝜉1
𝐷 = 𝜉2
𝐷 = 2,  𝜉0
𝐷 = 1 for 
diseased group and 𝜉1
𝑁 = 𝜉2
𝑁 = 10, 𝜉0
𝑁 = 1 for non-diseased group. Then suppose 
𝑓(𝒙) and 𝑔(𝒙) are the probability density function for diseased and non-diseased 




= 𝛼 + 𝛽1𝑥1 + 𝛽2𝑥2 
Let U = 𝛼 + 𝛽1𝑥1 + 𝛽2𝑥2 . It is easy to verify that U  is always the optimal 












 are given, 
then 𝛼, 𝛽1 and 𝛽2 would have an explicit expression: 




















Next we study the robustness of the methods. It means that the “diseased group” 
would include some non-diseased individuals and the “non-diseased group” would 
include some diseased individuals. We posit that the diseased group satisfies the 
distribution: 
𝑓(𝒙) = 𝜆1𝑓1(𝒙) + (1 − 𝜆1)𝑓0(𝒙) 
and the non-diseased group satisfies the distribution: 
𝑔(𝒙) = (1 − 𝜆0)𝑓1(𝒙) + 𝜆0𝑓0(𝒙) 
where 1 − 𝜆1 is the proportion of non-diseased individuals contained in the diseased 
group and 1 − 𝜆0  is the proportion of diseased individuals contained in the non-
diseased group. Here 𝑓1(𝒙) and 𝑓0(𝒙) refers to the probability density function of the 
bivariate exponential distribution for diseased and non-diseased populations described 
in this section.  
 
5.2 Distribution estimation and comparison 
 In this section, we will compare the distribution estimation of 𝜷 and 𝐴𝑈𝐶 while 
applying different methods described in Chapter 4. For all methods, we standardize 
‖𝜷‖2 = 1 , while ‖. ‖2  is the 𝐿2  norm. We fix 𝜉1
𝐷 = 𝜉2
𝐷 = 2,  𝜉0
𝐷 = 1  for the 
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diseased group, and vary 𝜉1
𝑁 = 𝜉2
𝑁 = 3/5/10, 𝜉0
𝑁 = 1 for the non-diseased group 
to simulate different magnitudes between these two groups. 
 First, we display the estimating results of the models proposed by Qin and Zhang 
(2010) and Chen et al. (2015) when 𝜆 = 1 and 𝜆 < 1:  
 
Figure 1. The ROC estimation results for 𝜆 = 1 (left panel) and 𝜆 = 0.8 (right 
panel) when 𝜉1
𝐷 = 𝜉2
𝐷 = 2 and 𝜉1
𝑁 = 𝜉2
𝑁 = 5 
 
 From the Figure 1 in the left panel, the estimations based on two models are both 
acceptable for non-robust case. For 𝜆 = 0.8, the estimations are still not bad for both 
models. If we take a comparison, Model 2 performs comparably better than Model 1 
for both robust and non-robust cases.  
Then, we could focus on the distribution estimation for 𝜷. Here we only test for 
𝛽2 since we have already standardized 𝜷. And we set confidence level α = 0.05 for 
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, the true value for 𝛽2 is equal to 
1/√2 ≈ 0.707. 
 We take 𝜉1
𝐷 = 𝜉2
𝐷 = 2  and 𝜉1
𝑁
= 𝜉2
𝑁 = 3  as an example to describe the 
results in detail. Other parameter settings can be analyzed in a similar way: 
 
 ① ② ③ 
𝜆0 𝜆1 Par. Bias MSE Type I Bias MSE Type I Bias MSE Type I 
1 1 𝛽2 -0.021 0.025 0.016 -0.017 0.023 0.127 -0.005 0.016 0.063 
0.8 0.8 𝛽2 -0.063 0.073 0.020 -0.083 0.081 0.006 -0.036 0.053 0.001 
0.6 0.6 𝛽2 -0.172 0.165 0.019 -0.151 0.165 0.000 -0.251 0.355 0.000 
Table 2. Method performances for estimating 𝛽2 while choosing different 𝜆0, 𝜆1 
when 𝜉1
𝐷 = 𝜉2
𝐷 = 2  and 𝜉1
𝑁
= 𝜉2
𝑁 = 3 
 
 Table 2 shows the bias, MSE and Type I error for three methods in different 𝜆0, 
𝜆1  settings. If we do not consider the robustness, that is 𝜆0 = 𝜆1 = 1 , all three 
proposed methods have an acceptable bias and MSE. If we compare these parameters 
more precisely, method ③ is comparably better than method ① and method ②. 
And from the Type I error, we compare the performance of the distribution estimation. 
From these three methods, Type I error of method ③  (0.063) is closest to the 
confidence level α = 0.05 , therefore this method has the best performance in 
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distribution estimation among three methods. And Type I error of method ① (0.016) 
is comparably small and Type I error of method ② (0.127) is comparably big, means 
that the distribution estimation of method ① is a little rough and the distribution 
estimation of method ② is a little specific compared with the true distribution. Here 
are their distribution estimations for a dataset showed by histograms, which is 
consistent to the analysis above: 
 
 
Figure 2. Histograms of the distribution estimation for three methods (graphs are 
listed by the order method ①、 ② and ③) 
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  And the Table 3 below shows Type II error for non-robust case. We roughly find 
that ③>②>① in performance because Type II error of method ③ has the fastest 
decreasing speed compared with method ① and method ② when 𝛽2 is away from 
the true value. But since the difference of 𝜉𝐷 and 𝜉𝑁 is not great, even when 𝛽2 =
0.15 or another side 𝛽2 = 0.95 , the Type II error for all three methods are still bigger 
than 0.050, showing that the Type II error for all three methods can not be controlled 
quite well. But this can be controlled much better when the magnitude is greater. 
 
𝛽2 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 0.50 
①  0.121 0.186 0.256 0.316 0.399 0.482 0.581 0.667 0.761 0.834 
②  0.038 0.066 0.093 0.133 0.197 0.256 0.344 0.432 0.518 0.627 
③  0.021 0.032 0.050 0.086 0.140 0.216 0.297 0.406 0.548 0.664 
𝛽2 0.55 0.60 0.65 0.70 0.75 0.80 0.85 0.90 0.95 1.00 
①  0.902 0.947 0.976 0.987 0.967 0.942 0.858 0.690 0.437 0.000 
②  0.726 0.803 0.851 0.875 0.866 0.794 0.666 0.483 0.238 0.000 
③  0.768 0.859 0.907 0.933 0.928 0.867 0.755 0.547 0.257 0.000 
Table 3. Comparison of Type II error for distribution estimation while 𝜆0 = 𝜆1 = 1 
𝜉1
𝐷 = 𝜉2
𝐷 = 2 and 𝜉1
𝑁 = 𝜉2




 Back to Table 2, we then focus on the robustness. It can be found the absolute value 
of bias for method ③ increase extremely quickly (from 0.005 to 0.251) and its Type I 
error suddenly decreases to 0, showing that method ③ is not suitable for robust case. 
Similar results and conclusions can be found for method ②, with its absolute value of 
bias increases from 0.017 to 0.151. And method ① seems to be the most stable method 
that even if its absolute value of bias increases a little bit (from 0.021 to 0.171) when 
𝜆0, 𝜆1 are decreasing, its Type I error is still at the same level (~0.02). 
- And here are the estimating results for three method when 𝜉1
𝐷 = 𝜉2
𝐷 = 2, 𝜉1
𝑁 =
𝜉2
𝑁 = 5 and 10: 
 
 ①  ② ③ 
𝜆0 𝜆1 Par. Bias MSE Type I Bias MSE Type I Bias MSE Type I 
1 1 𝛽2 -0.001 0.007 0.020 -0.010 0.007 0.097 -0.004 0.004 0.052 
0.8 0.8 𝛽2 -0.020 0.027 0.026 -0.027 0.029 0.002 -0.014 0.020 0.003 
0.6 0.6 𝛽2 -0.114 0.131 0.019 -0.121 0.134 0.000 -0.113 0.152 0.000 
Table 4. Method performances for estimating 𝛽2 while choosing different 𝜆0, 𝜆1 
when 𝜉1
𝐷 = 𝜉2
𝐷 = 2  and 𝜉1
𝑁
= 𝜉2






𝛽2 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 0.50 
① 0.000 0.000 0.000 0.001 0.003 0.008 0.028 0.092 0.216 0.413 
② 0.000 0.000 0.000 0.000 0.002 0.007 0.019 0.052 0.145 0.300 
③ 0.000 0.000 0.000 0.000 0.000 0.001 0.002 0.016 0.083 0.191 
𝛽2 0.55 0.60 0.65 0.70 0.75 0.80 0.85 0.90 0.95 1.00 
① 0.634 0.816 0.933 0.979 0.965 0.821 0.523 0.152 0.011 0.000 
② 0.481 0.679 0.835 0.898 0.815 0.615 0.334 0.098 0.007 0.000 
③ 0.408 0.643 0.868 0.946 0.882 0.663 0.301 0.041 0.000 0.000 
Table 5. Comparison of Type II error for distribution estimation while 𝜆0 = 𝜆1 = 1 
𝜉1
𝐷 = 𝜉2
𝐷 = 2 and 𝜉1
𝑁 = 𝜉2
𝑁 = 5 for different methods 
 
 ①  ② ③ 
𝜆0 𝜆1 Par. Bias MSE Type I Bias MSE Type I Bias MSE Type I 
1 1 𝛽2 -0.003 0.005 0.023 -0.009 0.005 0.108 -0.001 0.003 0.057 
0.8 0.8 𝛽2 -0.019 0.020 0.018 -0.015 0.020 0.003 -0.013 0.020 0.004 
0.6 0.6 𝛽2 -0.111 0.126 0.022 -0.120 0.130 0.000 -0.077 0.111 0.000 
Table 6. Method performances for estimating 𝛽2 while choosing different 𝜆0, 𝜆1 
when 𝜉1
𝐷 = 𝜉2
𝐷 = 2 and 𝜉1
𝑁
= 𝜉2





𝛽2 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 0.50 
① 0.000 0.000 0.000 0.000 0.000 0.001 0.002 0.007 0.068 0.215 
② 0.000 0.000 0.000 0.000 0.000 0.000 0.001 0.014 0.060 0.165 
③ 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.016 0.068 
𝛽2 0.55 0.60 0.65 0.70 0.75 0.80 0.85 0.90 0.95 1.00 
① 0.460 0.735 0.919 0.975 0.950 0.763 0.364 0.053 0.000 0.000 
② 0.383 0.637 0.829 0.896 0.814 0.547 0.218 0.027 0.001 0.000 
③ 0.246 0.545 0.821 0.945 0.870 0.536 0.160 0.008 0.000 0.000 
Table 7. Comparison of Type II error for distribution estimation while 𝜆0 = 𝜆1 = 1 
𝜉1
𝐷 = 𝜉2
𝐷 = 2 and 𝜉1
𝑁 = 𝜉2
𝑁 = 10 for different methods 
 




 settings in robust and non-robust case. We can analyze these results 
in a similar way to the previous setting. From all these settings, we conclude that the 
method ③ estimate the distribution best if we do not consider the robustness. It has 
the smallest MSE and bias and its Type I error is always closest to confidence level 
α = 0.05 even if magnitudes are different. For the other two methods, Type I error for 
method ① is comparably a little small (~0.02) while Type I error for method ② is 
comparably a little big (~0.10). Then if we consider the robust case, we find that method 
① is the most stable method that its Type I error for distribution estimation doesn’t 
change too much(~0.02). Method ② and method ③ perform not so well if we take 
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robustness into account, especially method ③ for small magnitude, its bias and MSE 
increase quickly when 𝜆0, 𝜆1 decrease. We also find similar opinion in Chen et al. 
(2015)’s paper that the exponential titling method cannot be correctly specified if 𝜆 <
1, corresponding to our analysis towards method ③. 
 If we focus on Type II error, we conclude that ③>②>① in performance. We can 
look at another parameter setting different from the discussion above. If we choose to 
take 𝜉1
𝐷 = 𝜉2
𝐷 = 2, 𝜉1
𝑁 = 𝜉2
𝑁 = 5 and Type II error=0.05 as the judgement point 
as an example, we find that for method ③, we have a Type II error smaller than 0.05 
if 𝛽2 < 0.430  or 𝛽2 > 0.898, while for method ②, we achieve this when 𝛽2 <
0.397  or 𝛽2 > 0.916, and for method ①, 𝛽2 should satisfy 𝛽2 < 0.368  or 𝛽2 >
0.942. 
 Then, we turn to the distribution estimation for 𝐴𝑈𝐶. While the biomarkers follow 
bivariate exponential distribution, the direct calculation for the true value 𝐴𝑈𝐶 would 
be not be a difficult task. Another approach is to numerically calculate P(𝑈𝐷 > 𝑈𝑁), 
here 𝑈𝐷 is the optimal combination of the data from the diseased group and 𝑈𝑁 is for 
the non-diseased group. The result of these two approaches should be equivalent. It 
should also be noticed that when we consider the robustness, the true value of 𝐴𝑈𝐶 
will change greatly. Here are the true value of 𝐴𝑈𝐶 for different 𝜉 and 𝜆 and the 





𝜆0 𝜆1 Par. 𝜉1
𝑁 = 𝜉2
𝑁 = 3 𝜉1
𝑁 = 𝜉2
𝑁 = 5 𝜉1
𝑁 = 𝜉2
𝑁 = 10 
1 1 𝐴𝑈𝐶 0.61975 0.75735 0.87943 
0.8 0.8 𝐴𝑈𝐶 0.57137 0.65120 0.72908 
0.6 0.6 𝐴𝑈𝐶 0.52448 0.55094 0.57750 
Table 8. True value for 𝐴𝑈𝐶 
 
 
  ①  ②  ③  
𝜆0 𝜆1 Par. Bias MSE Bias MSE Bias MSE 
𝜉1
𝑁 = 𝜉2
𝑁 = 3 
1 1 𝐴𝑈𝐶 0.018 7 × 10−4 0.018 7 × 10−4 0.013 5 × 10−4 
0.8 0.8 𝐴𝑈𝐶 0.023 9 × 10−4 0.022 8 × 10−4 0.005 3 × 10−4 
0.6 0.6 𝐴𝑈𝐶 0.029 0.001 0.028 0.001 0.007 3 × 10−4 
𝜉1
𝑁 = 𝜉2
𝑁 = 5 
1 1 𝐴𝑈𝐶 0.012 5 × 10−4 0.011 4 × 10−4 0.013 4 × 10−4 
0.8 0.8 𝐴𝑈𝐶 0.020 8 × 10−4 0.020 7 × 10−4 -0.013 5 × 10−4 
0.6 0.6 𝐴𝑈𝐶 0.026 0.001 0.024 9 × 10−4 -0.004 3 × 10−4 
𝜉1
𝑁 = 𝜉2
𝑁 = 10 
1 1 𝐴𝑈𝐶 0.010 3 × 10−4 0.010 3 × 10−4 0.012 3 × 10−4 
0.8 0.8 𝐴𝑈𝐶 0.014 5 × 10−4 0.014 5 × 10−4 -0.055 0.003 
0.6 0.6 𝐴𝑈𝐶 0.021 8 × 10−4 0.020 7 × 10−4 -0.022 8 × 10−4 




Table 8 shows the true value of 𝐴𝑈𝐶 in different cases and Table 9 shows the 
estimation results for 𝐴𝑈𝐶 for three methods. It is not surprising that method ① and 
② have almost the same bias and MSE, since these two methods have the same data-
generating and initial estimating process. The results in Table 9 are consistent to those 
results showed in Figure 1. However, from the bias for non-robust case, we also notice 
that the estimation for 𝐴𝑈𝐶 is not so good as the estimation for 𝛽2 for this sample 
size. Actually, the estimated distribution of 𝐴𝑈𝐶 is always more concentrated than 𝛽2. 
Therefore, taking those three existing methods to give a distribution estimation for 
𝐴𝑈𝐶  do not have quite good performance. Taking 𝜉1
𝑁 = 𝜉2
𝑁 = 5 as an example, 
confidence level α = 0.05: 
 
 ①  ②  ③ 
𝜆0 𝜆1 Par. Bias Type I Bias Type I Bias Type I 
1 1 𝐴𝑈𝐶 0.012 0.227 0.011 0.299 0.013 0.167 
0.8 0.8 𝐴𝑈𝐶 0.020 0.372 0.020 0.300 -0.013 0.999 
0.6 0.6 𝐴𝑈𝐶 0.026 0.532 0.024 0.000 -0.004 0.763 
Table 10. Method performances for estimating 𝐴𝑈𝐶 while choosing different 𝜆0, 
𝜆1 when 𝜉1
𝐷 = 𝜉2
𝐷 = 2 and 𝜉1
𝑁 = 𝜉2




From Table 10, we find that the hypothesis test perform badly for 𝐴𝑈𝐶 estimation 
for all these three methods. Although their bias seem acceptable for both robust and 
non-robust cases, their Type I errors are a little big compared with the confidence level 
α = 0.05. 
In short, the methods we have come out with are suitable for estimating the 
asymptotic distribution of 𝛽. For non-robust case, Method ③ is found to be the best 
method and for robust case, Method ① has the best performance. But these three 
methods do not have a good performance for estimating 𝐴𝑈𝐶. We probably need to 








Conclusion and discussion 
 
 In this study, we apply the optimal combination of multiple diagnostic test while 
using exponential tilting method proposed by Qin and Zhang (2010) and the monotone 
density ratio method proposed by Chen et al. (2015) to establish the asymptotic 
distribution for 𝜷 and 𝐴𝑈𝐶. By applying bootstrapping and resampling, we come out 
with three methods and make comparison to their performances.  
 From the simulation results, we find that the estimated distributions of 𝜷 are not 
so central-concentrated than 𝐴𝑈𝐶  but have better estimating accuracy for their 
estimations. If we do not consider the robustness and if we set the confidence level α =
0.05, method ③ has the best approximation for the distribution of β with about 
0.05~0.06 Type I error and also perform best for Type II error. And if we take the 
robustness into account, method ① seems to be the most stable one. Its Type I error 
remains to be about 0.02 for all λ we have tested.  
 As we have concluded above, those three methods we come out have acceptable 
results for estimating the asymptotic distribution for 𝜷  and each method has its 
advantages. However, if we apply our methods to estimate 𝐴𝑈𝐶, those methods work 
not so well as expected. Maybe it is because that the asymptotic distribution of 𝐴𝑈𝐶 
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is more central-concentrated. Therefore, the hypothesis test towards 𝐴𝑈𝐶  may be 
more sensitive to the bias, and it needs a method with higher accuracy for estimating 
the distribution than estimating for 𝜷. 
 In conclusion, we have successfully given an estimation towards the asymptotic 
distribution of 𝜷  with good accuracy. And about 𝐴𝑈𝐶 , the estimating part still 
remains to be an open question for future studies. We can perhaps turn to discover some 
methods with higher accuracy in estimation which may work for estimating 𝐴𝑈𝐶 . 
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